New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 13, 2012
09:17 EDTSRPTSarepta Therapeutics 4.95M share Spot Secondary priced at $25.25
The deal priced at the high end of the $25.00-$25.25 range and was increased to $125M in common stock. Lazard Capital acted as sole book running manager for the offering.
News For SRPT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for SRPT

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use